This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.83% per year. These returns cover a period from January 1, 1988 through January 5, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Microcap Article: Archive
Friedman Upgraded to Outperform on Synergies, BV Value & Capacity
by Zacks Equity Research
FRD's upgrade to Outperform highlights synergy gains, capacity growth and a valuation still near book value.
FRDNegative Net Change
industrial-products
Zacks Initiates Coverage of Inspire Veterinary With Underperform Recommendation
by Debasmita Chatterjee
Find out why Zacks assigns an "Underperform" rating to Inspire Veterinary, being the first on Wall Street to initiate coverage on the stock. Explore how steep losses, funding risks, and weak revenue trends challenge its ambitious expansion and new digital ventures.
consumer-staples
ImmuCell's Two-Product Edge in Cattle Health Fuels Growth
by Urbashi Dutta
ICCC's innovative, antibiotic-free cattle health products drive margin recovery, real-world adoption and stock gains.
ICCCNegative Net Change
medical
ZRS Chart of the Month
by John Blank
Info Tech (11.08) remains richly overpriced, based on valuations, +56% over the median. That is the "AI" froth factor. Factor in high tech mega-cap P/E multiples too.
asset-allocation
Zacks December View on Equity Markets
by John Blank
All year long, stock market bulls have been trumpeting the AI data center trade. Let's look into the major semi-chip ETF, to see what the semi-chip returns status is.
asset-allocation
International: Update on Global Regions
by John Blank
"During the fourth quarter, the U.S. Dollar Index increased by 7.6% (to 108.49 from 100.78)."
asset-allocation
December Sell-Side and Buy-Side - Consensus at a Glance
by John Blank
Outside consensus was for 7,927. That latest consensus was (+21.2%) above a closing price of 6,538.
asset-allocation
December Asset Allocation Guidelines
by John Blank
5 different frameworks specify portfolio risk tolerance: from Risky "Max Growth" to Conservative "Income." Choose one that fits you.
asset-allocation
CRWS Upgraded to Outperform on Cost Reset, Valuation & Dividend Yield
by Zacks Equity Research
Crown Crafts gains an upgrade as cost cuts, tariff workarounds and a double-digit dividend reshape its risk/reward profile.
CRWSNegative Net Change
consumer-discretionary
Kodak's Turnaround Signals Rising Investment Appeal in 2025
by Urbashi Dutta
KODK is boosting margins faster than sales, scaling AM&C, riding on film demand and restoring print profits. A $600M pension reversion should slash debt and add flexibility.
KODKNegative Net Change
tech-stocks